-transparent.png){kind=logo}
We have studied immunoglobulin allotypes (GM and KM) in 101 patients with Crohn's disease, 51 patients with ulcerative colitis, and 99 healthy local blood donor controls. In addition, protease inhibitor (PI) types were examined in a random subset of patients and in all controls. No significant differences were found between Crohn's disease patients and controls, or between ulcerative colitis patients and controls, in the frequencies of GM phenotypes, GM haplotypes, KM phenotypes, or PI phenotypes.
Related Publications
L L Field, and
N Boyd, and
T J Bowen, and
J K Kelly, and
L R Sutherland
January 2004,
Immunogenetics,
L L Field, and
N Boyd, and
T J Bowen, and
J K Kelly, and
L R Sutherland
January 1978,
Human heredity,
L L Field, and
N Boyd, and
T J Bowen, and
J K Kelly, and
L R Sutherland
November 2000,
Vaccine,
L L Field, and
N Boyd, and
T J Bowen, and
J K Kelly, and
L R Sutherland
April 1988,
Cancer genetics and cytogenetics,
L L Field, and
N Boyd, and
T J Bowen, and
J K Kelly, and
L R Sutherland
January 2001,
Experimental and clinical immunogenetics,
L L Field, and
N Boyd, and
T J Bowen, and
J K Kelly, and
L R Sutherland
January 1975,
Human heredity,
L L Field, and
N Boyd, and
T J Bowen, and
J K Kelly, and
L R Sutherland
December 1981,
Journal of immunogenetics,
L L Field, and
N Boyd, and
T J Bowen, and
J K Kelly, and
L R Sutherland
January 1982,
Human genetics,
L L Field, and
N Boyd, and
T J Bowen, and
J K Kelly, and
L R Sutherland
January 1988,
American journal of physical anthropology,
L L Field, and
N Boyd, and
T J Bowen, and
J K Kelly, and
L R Sutherland
January 1979,
Human genetics,
